In the present study, we found that knockdown of HAPLN1, a key gene in the ECM, significantly promoted HF cell viability and reduced apoptosis, cardiac hypertrophy and oxidative stress response, which has not been reported before. This evidence concerns the gene HAPLN1 and cardiac hypertrophy.